CINGULATE -CW23 (CINGW:NASDAQ)
$0.0065 0.003 (85.7143%)
Analysed CINGULATE -CW23 (CINGW:NASDAQ) News Sources
CING: Building Its Cash Position
19-05-2026
yahoo.com
Cingulate Receives Complete Response Letter from FDA for CTx-1301
02-06-2026
yahoo.com
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26
04-06-2026
yahoo.com
Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®
02-07-2026
yahoo.com
Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology
30-07-2026
yahoo.com
Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
11-08-2026
yahoo.com
Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
13-08-2026
yahoo.com
CING: Second Quarter Results
19-08-2026
yahoo.com
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
17-09-2026
yahoo.com
Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301
16-06-2026
yahoo.com
What is the current price of CINGULATE -CW23 (CINGW:NASDAQ)?
The current price of CINGULATE -CW23 (CINGW:NASDAQ) is $0.0065.
CINGULATE -CW23 (CINGW:NASDAQ) absolute price change since previous trading day?
The absolute price change of CINGULATE -CW23 (CINGW:NASDAQ) since the previous trading day is $0.003.
CINGULATE -CW23 (CINGW:NASDAQ) percentage price change since previous trading day?
The percentage price change of CINGULATE -CW23 (CINGW:NASDAQ) since the previous trading day is 85.7143%.
What is the most recent average sentiment score for CINGULATE -CW23 (CINGW:NASDAQ)?
The most recent average sentiment score for CINGULATE -CW23 (CINGW:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for CINGULATE -CW23 (CINGW:NASDAQ)?
The most recent sentiment for CINGULATE -CW23 (CINGW:NASDAQ) is .
SEC-8K** Filing Available For CINGULATE -CW23 (CINGW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.